Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center

被引:0
作者
Botella, Carmen [1 ]
Galian, Jose Antonio [1 ]
Jimenez-Coll, Victor [1 ]
Fernandez-Gonzalez, Marina [1 ]
Morales, Francisco [2 ]
Martinez-Gomez, Gloria [3 ]
Gonzalez-Lopez, Rosana [1 ]
Alegria, Maria Jose [1 ]
Moya, Maria Rosa [1 ]
Martinez-Banaclocha, Helios [1 ]
Minguela, Alfredo [1 ]
Legaz, Isabel [4 ]
Llorente, Santiago [2 ]
Muro, Manuel [1 ]
机构
[1] Univ Clin Hosp Virgen Arrixaca, Biomed Res Inst Murcia IMIB, Immunol Serv, Murcia 30120, Spain
[2] Univ Clin Hosp Virgen Arrixaca, Biomed Res Inst Murcia IMIB, Nephrol Serv, Murcia 30120, Spain
[3] Univ Clin Hosp Virgen Arrixaca, Biomed Res Inst Murcia IMIB, Urol Serv, Murcia 30120, Spain
[4] Univ Murcia, Biomed Res Inst Murcia IMIB, Fac Med, Dept Legal & Forens Med,Reg Campus Int Excellence, Murcia 30100, Spain
来源
LIFE-BASEL | 2024年 / 14卷 / 11期
关键词
donor-derived circulating free DNA (dd-cfDNA); kidney transplant; graft rejection; biomarker; non-rejection (NR); antibody-mediated rejection (ABMR); borderline rejection (BR); T-cell-mediated rejection (TCMR); TRANSPLANTATION; REJECTION;
D O I
10.3390/life14111491
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
(1) Background: donor-derived circulating free DNA (dd-cfDNA), an innovative biomarker with great potential for the early identification and prevention of graft damage. (2) Methods: Samples were collected prospectively and the study was performed retrospectively to analyze dd-cfDNA plasma levels in 30 kidney transplant patients during their post-transplant follow-up (15 days, 3, 6, and 9 months), to determine if the result could be of interest in the identification of possible adverse events, especially rejection. The aim was to verify whether the data on sensitivity, specificity, NPV, and PPV compare with reference values and creatinine values. (3) Results: We observed levels of dd cfDNA > 1% in six of nine patients with active rejection (ABMR or TCMR) and elevated values (>0.5%) in two other patients in this rejection group. Our results show low values of sensitivity = 50%, specificity = 61.11%, rejection NPV = 64.71%, and rejection PPV = 46.13% of the technique compared to reference values previously published. With respect to creatinine, only for TCRM, we observed better results for dd-cfDNA in these parameters than in creatinine. Also, our data suggest that dd-cfDNA could help to differentiate those patients with dnDSAs that are going to through rejection better than creatinine, specially at 15 d post transplant. In this study, this appears to have no positive predictive value for borderline rejection (BR) or TCMR IA. (4) Conclusions: plasma levels of dd-cfDNA could be considered an additional or alternative biomarker for graft rejection monitoring in early post-kidney transplant up to several months before its clinical presentation, especially for patients with suspected TCMR or ABMR.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management [J].
Qazi, Yasir ;
Patel, Anup ;
Fajardo, Mark ;
McCormick, Sarah ;
Fehringer, Gordon ;
Ahmed, Ebad ;
Malhotra, Meenakshi ;
Demko, Zachary P. ;
Billings, Paul R. ;
Tabriziani, Hossein ;
Gauthier, Philippe .
TRANSPLANTATION PROCEEDINGS, 2021, 53 (10) :2866-2872
[22]   Role of Donor-derived Cell-free DNA In Predicting Short-term Allograft Health In Liver Transplant Recipients [J].
Jana, Koustav ;
Rammohan, Ashwin ;
Ramani, Avinash ;
Gunasekaran, Bhavani ;
Vij, Mukul ;
Ramamoorthi, Maharani ;
Jayakanthan, Nivethitha ;
Kaliamoorthy, Ilankumaran ;
Ramani, Agragesh ;
Rela, Mohamed .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (06)
[23]   Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study [J].
Bu, Lihong ;
Gupta, Gaurav ;
Pai, Akshta ;
Anand, Sanjiv ;
Stites, Erik ;
Moinuddin, Irfan ;
Bowers, Victor ;
Jain, Pranjal ;
Axelrod, David A. ;
Weir, Matthew R. ;
Wolf-Doty, Theresa K. ;
Zeng, Jijiao ;
Tian, Wenlan ;
Qu, Kunbin ;
Woodward, Robert ;
Dholakia, Sham ;
De Golovine, Aleskandra ;
Bromberg, Jonathan S. ;
Murad, Haris ;
Alhamad, Tarek .
KIDNEY INTERNATIONAL, 2022, 101 (04) :793-803
[24]   Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients [J].
Keller, Michael ;
Mutebi, Cedric ;
Shah, Pali ;
Levine, Deborah ;
Aryal, Shambhu ;
Iacono, Aldo ;
Timofte, Irina ;
Mathew, Joby ;
Varghese, Anu ;
Giner, Cassandra ;
Agbor-Enoh, Sean .
JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (04) :901-909
[25]   Donor-derived cell-free DNA for detection of acute rejection in lung transplant recipients [J].
Yavuz, Goekce ;
Walter, Julia ;
Hirv, Kaimo ;
Wachter, Oliver ;
Dick, Andrea ;
Kovacs, Julia ;
Zimmermann, Julia ;
Glueck, Olaf M. ;
Vorstandlechner, Maximilian ;
Samm, Nicole ;
Fertmann, Jan M. ;
Sienel, Wulf ;
Michel, Sebastian ;
Irlbeck, Michael ;
Kneidinger, Nikolaus ;
Hatz, Rudolf ;
Behr, Juergen ;
Schneider, Christian ;
Kauke, Teresa .
FRONTIERS IN IMMUNOLOGY, 2025, 16
[26]   Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study [J].
Bravo, Marta Jimenez-Blanco ;
Perez-Gomez, Laura ;
Hernandez-Perez, Francisco J. ;
Arellano-Serrano, Carlos ;
Torres-Sanabria, Mario ;
Gomez-Bueno, Manuel ;
Oteo-Dominguez, Juan F. ;
Mingo-Santos, Susana ;
Segovia-Cubero, Javier .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[27]   Donor-derived cell-free DNA and renal allograft rejection in surveillance biopsies and indication biopsies [J].
Chang, Jae-Hyung ;
Verduzco, Hector Alvarado ;
Toma, Katherine ;
Sritharan, Sharlinee ;
Mohan, Sumit ;
Husain, Syed Ali .
CLINICAL TRANSPLANTATION, 2022, 36 (04)
[28]   Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation [J].
Agbor-Enoh, Sean ;
Wang, Yan ;
Tunc, Ilker ;
Jang, Moon Kyoo ;
Davis, Andrew ;
De Vlaminck, Iwijn ;
Luikart, Helen ;
Shah, Pali D. ;
Timofte, Irina ;
Brown, Anne W. ;
Marishta, Argit ;
Bhatti, Kenneth ;
Gorham, Sasha ;
Fideli, Ulgen ;
Wylie, Jennifer ;
Grimm, David ;
Goodwin, Natalie ;
Yang, Yanqin ;
Patel, Kapil ;
Zhu, Jun ;
Laconoad, Aldo ;
Orens, Jonathan B. ;
Nathan, Steven D. ;
Marboe, Charles ;
Berry, Gerald J. ;
Quake, Stephen R. ;
Khush, Kiran ;
Valantine, Hannah A. .
EBIOMEDICINE, 2019, 40 :541-553
[29]   Remote monitoring using donor-derived, cell-free DNA after kidney transplantation during the coronavirus disease 2019 pandemic [J].
Potter, Steven R. ;
Hinojosa, Randall ;
Miles, Cliff D. ;
O'Brien, Dan ;
Ross, David J. .
KIDNEY RESEARCH AND CLINICAL PRACTICE, 2020, 39 (04) :495-500
[30]   Donor-Derived Cell-Free DNA in Kidney Transplantation: Origins, Present and a Look to the Future [J].
Kant, Sam ;
Brennan, Daniel C. .
MEDICINA-LITHUANIA, 2021, 57 (05)